In addition, we did not detect mesothelin-specific antibodies in sera harvested 90 days after tumor challenge from combination treated mice by using flow cytometry-based approach previously described [26], but the presence of these antibodies cannot be completely excluded in view of comparatively low sensitivity of this approach and possibly suboptimal time point for sera collection. The gene discussed is MSLN; the disease is neoplasm.